Cuba vs Hungary: The number of people with susceptibility test result for rifampicin
Cuba
133
in 2021
Hungary
142
in 2021
Cuba rank
104th
Hungary rank
103rd
The number of people with susceptibility test result for rifampicin over time
- Cuba
- Hungary
How they compare
Hungary currently reports 142 against 133 in Cuba, a difference of 9.
That makes Hungary's figure about 1.1 times Cuba's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cuba ahead.
Cuba ranks 104th and Hungary ranks 103rd of 155 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cuba | Hungary | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 316.33 | 277.33 | 39 | Cuba |
| 2020s | 161.5 | 149 | 12.5 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cuba or Hungary?
- Hungary, at 142 against 133 in Cuba as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cuba and Hungary?
- 9, with Hungary ahead.
- How many years of comparable data are there for Cuba and Hungary?
- 5 years are reported by both, from 2017 to 2021.
- How do Cuba and Hungary rank globally for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 104th and Hungary ranks 103rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.